CLINICAL_TRIALS
research
· 2016-12-08
Clinical Trial Update: Prospective Study of Frontline H Pylori Eradication in the Treatment of Early-stage Extragastric MALT Lymphoma
Summary
A prospective study evaluating first-line Helicobacter pylori eradication for early-stage extragastric mucosa-associated lymphoid tissue lymphoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: National Taiwan University Hospital | Conditions: Mucosa-Associated Lymphoid Tissue Lymphoma | Status: UNKNOWN